| Application no. and date | 10816293.4 (espacenet) (Federated) (European Patent Register), 20100914 | | Patent/reg. no. and date | DK/EP 2477499, 20180411 | | Publication date | 20120725 | | Priority no. and date | US 242238 P, 20090914, US 244250 P, 20090921 | | EP pub. no. and date |
EP 2477499 20120725 | | Effective date | | | Applicant/owner | SillaJen Biotherapeutics, Inc., 450 Sansome Street, Suite 650
San Francisco, CA 94111, US | | Applicant ref. no. | P64737DK01 | | Inventor | KIRN, David, c/o Jennerex Inc.
One Market Street
Suite 2260
San Francisco, CA 94105, US,
BREITBACH, Caroline, c/o Jennerex Inc.
One Market Street
Suite 2260
San Francisco, CA 94105, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/4412 (2006.01) , A61K 35/768 (2015.01) , A61K 38/19 (2006.01) , A61P 35/04 (2006.01) | | Title | KOMBINATIONSKRÆFTTERAPI MED ONKOLYTISK VACCINIA-VIRUS | | Int. application no. | US2010048829 | | Int. publication no. | WO2011032180 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
